Evidence mapPaperPMID 40983370Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2025

Measuring associations between hormonal entropy, the prevalence of vasomotor symptoms, and menstrual dynamics.

J F Winkles, Nanette Santoro, Mary D Sammel, Samar R El Khoudary, Alicia Colvin, Sybil Crawford

Abstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J F WinklesDepartment of Epidemiology, Epidemiology Data Center, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.ORCID 0009-0007-6450-9809
Nanette SantoroDivision of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States.ORCID 0000-0001-9096-7490
Mary D SammelDepartment of Biostatistics and Informatics, Colorado School of Public Health, Aurora, Colorado, United States.ORCID 0000-0003-1248-4199
Samar R El KhoudaryDepartment of Epidemiology, University of Pittsburgh School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.ORCID 0000-0003-2913-0821
Alicia ColvinDepartment of Epidemiology, University of Pittsburgh School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.ORCID 0000-0001-5638-2747
Sybil CrawfordTan Chingfen Graduate School of Nursing, UMass Chan Medical School, Worcester, Massachusetts, United States.ORCID 0000-0001-6621-0439

Funding

The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old AgeU19AG063720 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sioban D Harlow · 2024 to 2024
$21.9M
WOMENS HEALTH ACROSS THE NATION--PITTSBURGHU01AG012546 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 1994 to 2005
$8.4M
WOMENS HEALTH ACROSS THE NATION--COORDINATING CENTERU01AG012553 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 1994 to 2005
$7.8M
WOMENS HEALTH ACROSS THE NATION--ENDOCRINE LABU01AG012495 · UNIVERSITY OF MICHIGAN AT ANN ARBOR · 1994 to 2005
$7.4M
WOMENS HEALTH ACROSS THE NATION--UCDAVISU01AG012554 · UNIVERSITY OF CALIFORNIA DAVIS · 1994 to 2005
$4.5M
WOMENS HEALTH ACROSS THE NATION--UCLAU01AG012539 · UNIVERSITY OF CALIFORNIA LOS ANGELES · 1994 to 2005
$4.5M
WOMENS HEALTH ACROSS THE NATION--CHICAGOU01AG012505 · RUSH UNIVERSITY MEDICAL CENTER · 1994 to 2005
$4.4M
Women's Health Across the Nation-New Jersey SiteU01AG012535 · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · 1994 to 2005
$4.0M
THE STUDY OF WOMEN'S HEALTH ACROSS THE NATION-MICHIGANU01NR004061 · UNIVERSITY OF MICHIGAN AT ANN ARBOR · 1994 to 2005
$4.0M
WOMENS HEALTH ACROSS THE NATION--MASSACHUSETTS GENERAL HU01AG012531 · MASSACHUSETTS GENERAL HOSPITAL · 1994 to 2005
$3.3M
HHS | NIH | National Institute of Nursing Research (NINR) U01NR004061HHS | NIH | National Institute on Aging (NIA) U01AG012495HHS | NIH | National Institute on Aging (NIA) U01AG012505HHS | NIH | National Institute on Aging (NIA) U01AG012531HHS | NIH | National Institute on Aging (NIA) U01AG012535HHS | NIH | National Institute on Aging (NIA) U01AG012539HHS | NIH | National Institute on Aging (NIA) U01AG012546HHS | NIH | National Institute on Aging (NIA) U01AG012553HHS | NIH | National Institute on Aging (NIA) U01AG012554HHS | NIH | National Institute on Aging (NIA) U19AG063720NIA NIH HHS U01 AG012495NIA NIH HHS U01 AG012505NIA NIH HHS U01 AG012531NIA NIH HHS U01 AG012535NIA NIH HHS U01 AG012539NIA NIH HHS U01 AG012546NIA NIH HHS U01 AG012553NIA NIH HHS U01 AG012554NIA NIH HHS U19 AG063720NINR NIH HHS U01 NR004061
6 · The paper itself

Abstract

This study investigates whether deviations in the regularity/complexity of urinary sex hormones relative to textbook "gold standard" (GS) menstrual cycle patterns are associated with vasomotor symptom (VMS) occurrence and how these relationships might relate to differences in hormonal profiles. A total of 549 midlife women provided daily urine-based measurements of follicle-stimulating hormone (FSH), estrogen conjugates (E1C), pregnanediol glucuronide (PDG), and luteinizing hormone (LH) over a complete menstrual cycle. Distribution and fuzzy entropy (DistEn and FuzzEn) were used to gauge hormone regularity/complexity, emphasizing structural complexity and temporal unpredictability, respectively. Entropy metrics were classified as being elevated or lowered relative to the GS and then evaluated in relation to VMS prevalence. These same entropy classifications were used to evaluate hormone profiles by referencing 11 dynamics indicative of normal or reproductively aging cycles. Elevated entropy was positively associated with the likelihood of VMS for PDG-DistEn and E1C-DistEn and negatively associated for PDG-FuzzEn, E1C-FuzzEn, and LH-FuzzEn. Lowered entropy was negatively associated with VMS likelihood for LH-FuzzEn and PDG-FuzzEn and positively associated for FSH-FuzzEn and E1C-DistEn. Entropy analysis provides useful insight into menstrual cycle dynamics and their associations with VMS. Specifically, entropy can identify different underlying states of hormonal dysregulation associated with increased VMS occurrence, potentially providing insights into VMS causes and treatments. Furthermore, entropy metrics for PDG show potential in gauging degrees of reproductive aging, which could help in addressing health risks associated with late/early menopause. Finally, entropy may contribute toward efforts in understanding how a woman's VMS experience will progress through the menopause transition.

Indexed as

Gonadal Steroid HormonesHot FlashesMenstrual CycleVasomotor SystemAdultEntropyEstrogensFemaleFollicle Stimulating HormoneHumansLuteinizing HormoneMiddle AgedPregnanediolPrevalenceEstrogensFollicle Stimulating HormoneGonadal Steroid HormonesLuteinizing HormonePregnanediolpregnanediol-3 alpha-glucuronideentropyhormonesmenopausemenstrual cyclevasomotor symptoms

Identifiers

PMID40983370
PMCPMC12671162

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.